Fig. 3From: Emerging nanomedicines for effective breast cancer immunotherapyUsing extracellular vesicles for efficient breast cancer immunotherapy. a Adding anti CD3 and anti Her2 antibodies on the surface of extracellular vesicles. b Binding of engineered extracellular vesicles to the CD3-positive T cells in blood circulation. c Recruitment of T cells to tumor microenvironment, consisting of the Her2-positive tumor cells through interaction of T cells-extracellular vesicles complex with Her2-positive cellsBack to article page